Sentinel lymph node detection in early stage uterine cervix carcinoma: A systematic review

Gynecologic Oncology

Volumn 106, Issue 3, 2007, Pages 604-613

  van de Lande, Jonas ^a   Torrenga, Bas ^a   Raijmakers, Pieter G H M ^a   Hoekstra, Otto S ^a   van Baal, Marchien W ^a   Brölmann, Hans A M ^a   Verheijen, René H M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Sentinel lymph node; Sentinel node detection rate; Sentinel node sensitivity; Uterine cervix carcinoma

Indexed keywords

DEXTRAN TC 99M; DISULFINE BLUE; ISOSULFAN BLUE; METHYLENE BLUE; PHYTATE TC 99M; SERUM ALBUMIN TC 99M; TECHNETIUM 99M; TECHNETIUM SULFUR COLLOID TC 99M;

CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER STAGING; CONFIDENCE INTERVAL; DATA ANALYSIS; DATA BASE; DATA EXTRACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; EMBASE; EXTERNAL VALIDITY; HISTOPATHOLOGY; HUMAN; INTERNAL VALIDITY; LAPAROSCOPY; LAPAROTOMY; MEDLINE; METHODOLOGY; PRIORITY JOURNAL; PUBLICATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; SCINTIGRAPHY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; STANDARD; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; UTERINE CERVIX CARCINOMA;

COLORING AGENTS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM COMPOUNDS; UTERINE CERVICAL NEOPLASMS;

EID: 34548118367     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.05.010     Document Type: Review

References (61)

1. Greenlee R.T., Hill-Harmon M.B., Murray T., and Thun M. Cancer statistics. CA Cancer J. Clin. 51 1 (2001 (Jan)) 15-36
2. Sawaya G.F., and Grimes D.A. New technologies in cervical cytology screening: a word of caution. Obstet. Gynecol. 94 2 (1999 (Aug)) 307-310
3. Benedetti-Panici P., Maneschi F., Scambia G., Greggi S., Cutillo G., D'Andrea G., et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol. Oncol. 62 1 (1996 (Jul)) 19-24
4. Delgado G., Bundy B.N., Zaino R., Sevin B.U., Creasman W.T., and Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol. Oncol. 38 3 (1990 (Sep)) 352-357
5. Di Stefano A.B., Acquaviva G., Garozzo G., Barbic M., Cvjeticanin B., Meglic L., et al. Lymph node mapping and sentinel node detection in patients with cervical carcinoma: a 2-year experience. Gynecol. Oncol. 99 3 (2005 (Dec)) 671-679
6. Tanaka Y., Sawada S., and Murata T. Relationship between lymph node metastases and prognosis in patients irradiated postoperatively for carcinoma of the uterine cervix. Acta Radiol. Oncol. 23 6 (1984) 455-459
7. Barranger E., Cortez A., Uzan S., Callard P., and Darai E. Value of intraoperative imprint cytology of sentinel nodes in patients with cervical cancer. Gynecol. Oncol. 94 1 (2004 (Jul)) 175-180
8. Benedet J.L., Odicino F., Maisonneuve P., Beller U., Creasman W.T., Heintz A.P., et al. Carcinoma of the cervix uteri. J. Epidemiol. Biostat. 6 1 (2001) 7-43
9. Delgado G., Bundy B.N., Fowler Jr. W.C., Stehman F.B., Sevin B.U., Creasman W.T., et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol. Oncol. 35 3 (1989 (Dec)) 314-320
10. Landoni F., Maneo A., Colombo A., Placa F., Milani R., Perego P., et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 350 9077 (1997 (Aug 23)) 535-540
11. Lin Y.S., Tzeng C.C., Huang K.F., Kang C.Y., Chia C.C., and Hsieh J.F. Sentinel node detection with radiocolloid lymphatic mapping in early invasive cervical cancer. Int. J. Gynecol. Cancer 15 2 (2005 (Mar)) 273-277
12. Magrina J.F., Goodrich M.A., Lidner T.K., Weaver A.L., Cornella J.L., and Podratz K.C. Modified radical hysterectomy in the treatment of early squamous cervical cancer. Gynecol. Oncol. 72 2 (1999 (Feb)) 183-186
13. Michel G., Morice P., Castaigne D., Leblanc M., Rey A., and Duvillard P. Lymphatic spread in stage Ib and II cervical carcinoma: anatomy and surgical implications. Obstet. Gynecol. 91 3 (1998 (Mar)) 360-363
14. Sakuragi N., Satoh C., Takeda N., Hareyama H., Takeda M., Yamamoto R., et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with I.B. Stages, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer 85 7 (1999 (Apr 1)) 1547-1554
15. Averette H.E., Nguyen H.N., Donato D.M., Penalver M.A., Sevin B.U., Estape R., et al. Radical hysterectomy for invasive cervical cancer. A 25-year prospective experience with the Miami technique. Cancer 71 4 Suppl. (1993 (Feb 15)) 1422-1437
16. Green J., Kirwan J., Tierney J., Vale C., Symonds P., Fresco L., et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst. Rev. 3 (2005) CD002225
17. Potter M.E., Alvarez R.D., Shingleton H.M., Soong S.J., and Hatch K.D. Early invasive cervical cancer with pelvic lymph node involvement: to complete or not to complete radical hysterectomy?. Gynecol. Oncol. 37 1 (1990 (Apr)) 78-81
18. Potter M.E., Alvarez R.D., Gay F.L., Shingleton H.M., Soong S.J., and Hatch K.D. Optimal therapy for pelvic recurrence after radical hysterectomy for early-stage cervical cancer. Gynecol. Oncol. 37 1 (1990 (Apr)) 74-77
19. Keys H.M., Bundy B.N., Stehman F.B., Muderspach L.I., Chafe W.E., Suggs III C.L., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N. Engl. J. Med. 340 15 (1999 (Apr 15)) 1154-1161
20. Rose P.G., Adler L.P., Rodriguez M., Faulhaber P.F., Abdul-Karim F.W., and Miraldi F. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J. Clin. Oncol. 17 1 (1999 (Jan)) 41-45
21. Whitney C.W., Sause W., Bundy B.N., Malfetano J.H., Hannigan E.V., Fowler Jr. W.C., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J. Clin. Oncol. 17 5 (1999 (May)) 1339-1348
22. Bipat S., Glas A.S., van der Velden J., Zwinderman A.H., Bossuyt P.M., and Stoker J. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol. Oncol. 91 1 (2003 (Oct)) 59-66
23. Scheidler J., Hricak H., Yu K.K., Subak L., and Segal M.R. Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA 278 13 (1997 (Oct 1)) 1096-1101
24. Cabanas R.M. An approach for the treatment of penile carcinoma. Cancer 39 2 (1977 (Feb)) 456-466
25. Cox C.E., Pendas S., Cox J.M., Joseph E., Shons A.R., Yeatman T., et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann. Surg. 227 5 (1998 (May)) 645-651
26. Morton D.L., Wen D.R., Wong J.H., Economou J.S., Cagle L.A., Storm F.K., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg. 127 4 (1992 (Apr)) 392-399
27. Echt M.L., Finan M.A., Hoffman M.S., Kline R.C., Roberts W.S., and Fiorica J.V. Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies. South. Med. J. 92 2 (1999 (Feb)) 204-208
28. Moore R.G., DePasquale S.E., Steinhoff M.M., Gajewski W., Steller M., Noto R., et al. Sentinel node identification and the ability to detect metastatic tumor to inguinal lymph nodes in squamous cell cancer of the vulva. Gynecol. Oncol. 89 3 (2003 (Jun)) 475-479
29. Veronesi U., Paganelli G., Galimberti V., Viale G., Zurrida S., Bedoni M., et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 349 9069 (1997 (Jun 28)) 1864-1867
30. Medl M., Peters-Engl C., Schutz P., Vesely M., and Sevelda P. First report of lymphatic mapping with isosulfan blue dye and sentinel node biopsy in cervical cancer. Anticancer Res. 20 2B (2000 (Mar)) 1133-1134
31. Cochrane Collaboration. The Cochrane Manual. www.cochrane.org/admin/manual.htm; 2005.
32. Deville W.L., Buntinx F., Bouter L.M., Montori V.M., de Vet H.C., van der Windt D.A., et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med. Res. Methodol. 2 3 (2002 (Jul)) 9
33. Verheijen R.H.M., Pijpers R.J., van Diest P.J., Burger C.W., Buist M.R., and Kenemans P. Sentinel node detection in cervical cancer. Obstet. Gynecol. 96 1 (2000 (Jul)) 135-138
34. Li B., Zhang W.H., Liu L., Wu L.Y., Zhang R., and Li N. Sentinel lymph node identification in patients with early stage cervical cancer undergoing radical hysterectomy and pelvic lymphadenectomy. Chin. Med. J. (Engl.) 117 6 (2004 (Jun)) 867-870
35. Gil-Moreno A., Diaz-Feijoo B., Roca I., Puig O., Benavente M.A., Aguilar I., et al. Total laparoscopic radical hysterectomy with intraoperative sentinel node identification in patients with early invasive cervical cancer. Gynecol. Oncol. 96 1 (2005 (Jan)) 187-193
36. Malur S., Krause N., Kohler C., and Schneider A. Sentinel lymph node detection in patients with cervical cancer. Gynecol. Oncol. 80 2 (2001 (Feb)) 254-257
37. Dargent D., Martin X., and Mathevet P. Laparoscopic assessment of the sentinel lymph node in early stage cervical cancer. Gynecol. Oncol. 79 3 (2000 (Dec)) 411-415
38. Angioli R., Palaia I., Cipriani C., Muzii L., Calcagno M., Gullotta G., et al. Role of sentinel lymph node biopsy procedure in cervical cancer: a critical point of view. Gynecol. Oncol. 96 2 (2005 (Feb)) 504-509
39. Hubalewska A., Sowa-Staszczak A., Huszno B., Markocka A., Pitynski K., Basta A., et al. Use of Tc99m-nanocolloid for sentinel nodes identification in cervical cancer. Nucl. Med. Rev. Cent. East Eur. 6 2 (2003) 127-130
40. Lambaudie E., Collinet P., Narducci F., Sonoda Y., Papageorgiou T., Carpentier P., et al. Laparoscopic identification of sentinel lymph nodes in early stage cervical cancer: prospective study using a combination of patent blue dye injection and technetium radiocolloid injection. Gynecol. Oncol. 89 1 (2003 (Apr)) 84-87
41. Lantzsch T., Wolters M., Grimm J., Mende T., Buchmann J., Sliutz G., et al. Sentinel node procedure in Ib cervical cancer: a preliminary series. Br. J. Cancer 85 6 (2001 (Sep 14)) 791-794
42. Levenback C.F., Coleman R.L., Burke T.W., Lin W.M., Erdman W., Deavers M., et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J. Clin. Oncol. 20 3 (2002 (Feb 1)) 688-693
43. Marchiole P., Buenerd A., Scoazec J.Y., Dargent D., and Mathevet P. Sentinel lymph node biopsy is not accurate in predicting lymph node status for patients with cervical carcinoma. Cancer 100 10 (2004 (May 15)) 2154-2159
44. Martinez-Palones J.M., Gil-Moreno A., Perez-Benavente M.A., Roca I., and Xercavins J. Intraoperative sentinel node identification in early stage cervical cancer using a combination of radiolabeled albumin injection and isosulfan blue dye injection. Gynecol. Oncol. 92 3 (2004 (Mar)) 845-850
45. Niikura H., Okamura C., Akahira J., Takano T., Ito K., Okamura K., et al. Sentinel lymph node detection in early cervical cancer with combination 99mTc phytate and patent blue. Gynecol. Oncol. 94 2 (2004 (Aug)) 528-532
46. O'Boyle J.D., Coleman R.L., Bernstein S.G., Lifshitz S., Muller C.Y., and Miller D.S. Intraoperative lymphatic mapping in cervix cancer patients undergoing radical hysterectomy: a pilot study. Gynecol. Oncol. 79 2 (2000 (Nov)) 238-243
47. Pijpers R.J., Buist M.R., van Lingen A., Dijkstra J., van Diest P.J., Teule G.J., et al. The sentinel node in cervical cancer: scintigraphy and laparoscopic gamma probe-guided biopsy. Eur. J. Nucl. Med. Mol. Imaging 31 11 (2004 (Nov)) 1479-1486
48. Rhim C.C., Park J.S., Bae S.N., and Namkoong S.E. Sentinel node biopsy as an indicator for pelvic nodes dissection in early stage cervical cancer. J. Korean Med. Sci. 17 4 (2002 (Aug)) 507-511
49. Rob L., Strnad P., Robova H., Charvat M., Pluta M., Schlegerova D., et al. Study of lymphatic mapping and sentinel node identification in early stage cervical cancer. Gynecol. Oncol. 98 2 (2005 (Aug)) 281-288
50. Roca I., Caresia A.P., Gil-Moreno A., Pifarre P., Aguade-Bruix S., Castell-Conesa J., et al. Usefulness of sentinel lymph node detection in early stages of cervical cancer. Eur. J. Nucl. Med. Mol. Imaging 32 10 (2005 (Oct)) 1210-1216
51. Silva L.B., Silva-Filho A.L., Traiman P., Triginelli S.A., de Lima C.F., Siqueira C.F., et al. Sentinel node detection in cervical cancer with (99m)Tc-phytate. Gynecol. Oncol. 97 2 (2005 (May)) 588-595
52. van Dam P.A., Hauspy J., Vanderheyden T., Sonnemans H., Spaepen A., Eggenstein G., et al. Intraoperative sentinel node identification with Technetium-99m-labeled nanocolloid in patients with cancer of the uterine cervix: a feasibility study. Int. J. Gynecol. Cancer 13 2 (2003 (Mar)) 182-186
53. Yong W.S., Wong C.Y., Lee J.S., Soo K.C., Tan P.H., and Goh A.S. Single institution's initial experience with sentinel lymph node biopsy in breast cancer patients. ANZ J. Surg. 73 6 (2003 (Jun)) 416-421
54. Chung Y.A., Kim S.H., Sohn H.S., Chung S.K., Rhim C.C., and Namkoong S.E. Usefulness of lymphoscintigraphy and intraoperative gamma probe detection in the identification of sentinel nodes in cervical cancer. Eur. J. Nucl. Med. Mol. Imaging 30 7 (2003 (Jul)) 1014-1017
55. Kettlewell S., Moyes C., Bray C., Soutar D.S., MacKay A., Byrne D., et al. Value of sentinel node status as a prognostic factor in melanoma: prospective observational study. BMJ 332 7555 (2006 (Jun 17)) 1423
56. Borgstein P.J., Pijpers R.J., Comans E.F., van Diest P.J., Boom R.P., and Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J. Am. Coll. Surg. 186 3 (1998 (Mar)) 275-283
57. Veronesi U., Paganelli G., Viale G., Luini A., Zurrida S., Galimberti V., et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N. Engl. J. Med. 349 6 (2003 (Aug 7)) 546-553
58. Van Trappen P.O., and Pepper M.S. Lymphatic dissemination of tumour cells and the formation of micrometastases. Lancet Oncol. 3 1 (2002 (Jan)) 44-52
59. Gimbergues P., Dauplat M.M., Cayre A., Durando X., Le B.G., Finat-Duclos F., et al. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category. Eur. J. Surg. Oncol. 33 1 (2007 (Feb)) 16-22 (Epub 2006 Oct 27)
60. Leveuf J., and Godard H. Les lymphatiques de l'uterus. Rev. Chir. 61 (1923) 219-248
61. Plante M., Renaud M.C., Tetu B., Harel F., and Roy M. Laparoscopic sentinel node mapping in early-stage cervical cancer. Gynecol. Oncol. 91 3 (2003 (Dec)) 494-503